Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)Efficacy and Safety of KW21052 Compared to Lyrica in the Diabetic Patients With Neuropathic Pain
Phase 3
- Conditions
- Diabetic Neuropathy
- Interventions
- First Posted Date
- 2013-05-29
- Last Posted Date
- 2013-05-29
- Lead Sponsor
- KunWha Pharmaceutical Co., Ltd.
- Target Recruit Count
- 394
- Registration Number
- NCT01863810
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
News
No news found